Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease

Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease

Waning immunity following administration of mRNA-based COVID-19 vaccines remains a concern for many health systems. We undertook a study to determine if recent reports of waning for severe disease could have been attributed to design-related bias by conducting a study only among those detected with...

Full description

Bibliographic Details
Main Authors: Abdulmajeed, J. (Author), Al Khal, A. (Author), Albayat, S.S.A (Author), Al-Kuwari, M.G (Author), Al-Romaihi, H.E (Author), Al-Shamali, M.H.M.A (Author), Al-Thani, M.H (Author), Baaboura, R. (Author), Bansal, D. (Author), Bertollini, R. (Author), Chivese, T. (Author), Cyprian, F.S (Author), Doi, S.A.R (Author), Farag, E. (Author), Himatt, S.M (Author), Kaleeckal, A.H (Author), Kandy, M.C (Author), Khogali, H.S (Author), Latif, A.N (Author), Mundodan, J.M.A (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
case-control
conditional effectiveness
COVID-19
mRNA vaccine
vaccine effectiveness
waning
Online Access:View Fulltext in Publisher

Similar Items

Similar Items